With over $875 million under management, ProQuest Investments has 12 deal professionals and three offices in Princeton, San Diego, and Montreal. The firm invests in healthcare companies seeking financings ranging from seed to late-stage, with a special expertise in therapeutics. ProQuest Investments has a proven superior track record with over 40 investments in diverse therapeutic categories such as oncology, pain, and infectious disease. The firm seeks to build long-term, mutually beneficial partnerships with outstanding entrepreneurs and closed its fourth fund of $425 million at the end of 2006.